🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
The primary objective of the trial is to evaluate the efficacy of fluticaso...
Status
Recruiting
Location
Teva Investigational Site 12087
Start Date
2024-12-12
Trial ID
NCT06664619
A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10-13
Trial ID
NCT02924688
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10453
Start Date
2013-01
Trial ID
NCT01772368
Treatments Being Tested
This is a randomized, multi-center, parallel-group, active-controlled, doub...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00394355
This is a multicenter, randomized, double-blind, double-dummy, parallel gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-04-04
Trial ID
NCT01822899
This study is to evaluate the safety and efficacy of fluticasone propionate...
Status
Completed
Location
Teva Investigational Site 13881
Start Date
2016-12-28
Trial ID
NCT02980133
Treatments Being Tested
The primary objective of this study was to evaluate the efficacy of flutica...
Status
Completed
Location
Teva Investigational Site 12429
Start Date
2014-06
Trial ID
NCT02141854
Treatments Being Tested
The objective of this clinical study was to evaluate the tolerability, safe...
Status
Completed
Location
OLV Hospital Aalst
Start Date
2021-05-18
Trial ID
NCT04876677
Treatments Being Tested